Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Nortec Quimica SA
WARNING LETTER
•Nortec Quimica SA•July 22, 2022

Nortec Quimica SA – FDA Warning Letter, Jul 22, 2022

Record Details

The FDA inspected Nortec Quimica SA, a drug manufacturing facility in Brazil, from July 18-22, 2022, identifying significant deviations from current Good Manufacturing Practice (CGMP) for active pharmaceutical ingredients (API). Consequently, the firm's API are deemed adulterated under 21 U.S.C. 351(a)(2)(B). Key violations include the failure to exercise sufficient controls over computerized systems, leading to unauthorized data access, changes, and omissions. Specifically, analysts could delete/overwrite data, over 100 deleted files were found, and stand-alone systems lacked unique user accounts, passwords, and backups. Additionally, the quality unit failed to adequately review batch production and laboratory control records prior to API distribution, neglecting complete raw data review from chromatography systems and lacking traceability controls for analytical worksheet forms. The FDA deemed the firm's responses inadequate, highlighting an overall lack of data integrity. The company is required to provide a comprehensive third-party assessment of computer system security, detailed plans for electronic data review and manual integration controls, a reanalysis plan for affected batches, and a global CAPA plan addressing data integrity lapses. A CGMP consultant is recommended. Failure to address these deviations may result in FDA withholding approvals and refusing admission of products into the U.S. A written response is required within 15 working days.

Company
Nortec Quimica SA
Inspection date
July 22, 2022
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Francis Godwin (Director)
View Company Profile

ID · 810f9765-efa5-43fe-a4c4-bb1b99e1142a

Violation Codes3
FD&C Act 801(a)(3)FD&C Act 501(a)(2)(B)21 U.S.C. 351(a)(2)(B)

Full citation text and observation details available on the Dashboard.

Other documents for Nortec Quimica SA
  • EIR - 2022-07-22July 22, 2022

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Nortec Quimica SA
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.